US7300682B2 - Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance - Google Patents

Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance Download PDF

Info

Publication number
US7300682B2
US7300682B2 US10/416,017 US41601703A US7300682B2 US 7300682 B2 US7300682 B2 US 7300682B2 US 41601703 A US41601703 A US 41601703A US 7300682 B2 US7300682 B2 US 7300682B2
Authority
US
United States
Prior art keywords
composition
acid
rna
coconut water
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime, expires
Application number
US10/416,017
Other versions
US20040067264A1 (en
Inventor
Muhammed Majeed
Vladimir Badmaev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Original Assignee
Sami Chemicals and Extracts Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Chemicals and Extracts Ltd filed Critical Sami Chemicals and Extracts Ltd
Priority to US10/416,017 priority Critical patent/US7300682B2/en
Assigned to SABINSA CORPORATION reassignment SABINSA CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BADMAEV, VLADIMIR, MAJEED, MUHAMMED
Publication of US20040067264A1 publication Critical patent/US20040067264A1/en
Assigned to SAMI LABS LTD. reassignment SAMI LABS LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SABINSA CORPORATION
Application granted granted Critical
Publication of US7300682B2 publication Critical patent/US7300682B2/en
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Definitions

  • the invention relates to nutritional, cosmetic and pharmaceutical compositions containing active ingredients from fresh green coconuts, and methods for obtaining the compositions.
  • coconut water is the liquid endosperm of Cocos nucifera L an is used as a supplement in media for the growth of plant tissue cultures.
  • the coconut fruit is unique in that it accumulates large amounts of this liquid over periods of a year or more in its life cycle.
  • the greatest amount of coconut water is found in young, green coconuts and provides nourishment for the growth of the solid endosperm (coconut meat) inside the hard shell of the fruit.
  • both the solid endosperm and the remaining coconut water serve as nutrients for the developing embryo and seedling.
  • coconut water serves as a natural reservoir of nutrients to promote tissue growth 1 .
  • the nutritional composition of coconut water obtained from fruits at different stages of maturity has been determined.
  • the medium is rich in proteins, amino acid sugars, vitamins, minerals and growth hormones (Table 1) essential to the promotion of tissue growth.
  • shikimic acids and quinic acids have been detected in samples of coconut water from fruits at different stages of maturity, with the maximum amounts being found in young green coconuts.
  • the probable role of these alicyclic acids in romatic biosynthesis indicates their importance in the developing coconut. They may also play a significant role in the nutrition of plant and tissue cultures.
  • RNA-phosphorus (RNA-P) content of coconut water was found to be consistently high at all levels of fruit maturity (Table 2).
  • the ratio of RNA-P/DNA-P was unusually high.
  • the role of RNA in amino acid transport and respiratory metabolism of living cells is well known.
  • the RNA of coconut water would therefore effectively carry out these and other functions as part of the metabolic machinery essential to the developing endosperm tissue of the coconut and therefore support the growth of other living cells as well, in tissue culture media.
  • Cytokinins are a class of plant growth substances (plant hormones) active in promoting cell division. They are also involved in cell growth and differentiation and in other physiological processes. A major cytokinin found in coconut milk was isolated using a standard procedure, the tobacco callus growth-promoting assay. The structure was determined to be a complex trans-zeatin riboside (G3A2-ZR). The authors of this study attributed at least 20% of the cytokinin activity in coconut milk to this compound 2 .
  • coconut water The nutritive properties of coconut water are well recognized in Oriental tradition. Immature coconuts are used as a glucose-electrolyte oral re-hydration solution for treatment of diarrhea 4 .
  • coconut water solids also provide a nutritive medium for beneficial microflora in the gastrointestinal tract.
  • a recent report also mentions the successful use of coconut water as a short-term intravenous hydration fluid 5 .
  • coconut water has been used traditionally as a nutritional beverage.
  • the FAO was recently granted a patent in the UK for the manufacture of bottled coconut water that retained all nutrients. This is the first patent given to a UN agency. Unlike existing methods their process did not use HTST pasteurization, wherein heat treatment would inactivate some of the biological activity of the coconut water.
  • Cocogro a natural product comprised of plant growth hormones and regulators, which enhances the growth of vegetables, legumes fruit trees, cereal crops, flowering plants, etc.
  • Green coconut milk is reported to be an effective culture medium for animal cells (Rev Bras Biol. 1970(Apr) 30:1:97-100) and Plasmodium (Trans. R. Soc. Trop. Med Hyg. 1989 83:5, 720).
  • coconut milk has been used traditionally on the skin as a nourishing agent, green coconut water provides unique nutrients for sustaining cell growth.
  • a protein fraction isolated from coconut water was absent in the milk (Birosel, DM et al. Rev. Farm Bioquim Univ Sao Paulo 1976 14:35-42).
  • Coconut milk is used in a facemask in U.S. Pat. No. 5,660,840 and in a plant growth regulating composition in U.S. Pat. No. 5654255.
  • coconut water was found to be safe for topical use. In laboratory studies, the material is shown to have no irritating effects on the skin, and the LD 50 value must be greater than 2000 mg/kg when administered through the skin. Accordingly, coconut water is nontoxic.
  • coconut water is described as an isotonic sports drink.
  • the comparative properties of coconut water and conventional sports drinks are listed in Table 3 7 :
  • compositions containing as active ingredients, components obtained from coconut water are specifically formulated for use in tissue culture media, more preferably, in supporting or culturing cells and mammalian tissues derived from ectoderm, mesoderm and endoderm.
  • composition may be used in topical applications, for example, skin and hair care formulations.
  • the composition may also be formulated into a nutritional supplement so as to be administered by ingestion or intravenously, thereby providing essential nutrients and repair material for the tissues.
  • the active ingredients of coconut water can be obtained by freeze-drying, and this simple method yields a unique and stable composition with optimum biological activity.
  • the inventive composition contains optimal amounts of growth hormones (cytokinins) and RNA-phosphorus (RNA-P), an optimal ratio of RNA-P/DNA-P, as well as desired concentrations of shikimic, quinic and indole-3-acetic acids.
  • cytokinins growth hormones
  • RNA-P RNA-phosphorus
  • shikimic, quinic and indole-3-acetic acids concentrations of shikimic, quinic and indole-3-acetic acids.
  • RNA-P/DNA-P ratio is 300:1 to 400:1. This is based on literature reports wherein the RNA-P of 20.05 mcg/g was associated with DNA-P 0.06 mcg/g of the alcohol-insoluble residue. RNA-P/DNA-P was therefore approximately 340:1.
  • Another object of the invention is a unique process for preserving the natural growth promoting properties of green coconut water.
  • the nutritional properties of green coconut water are optimized by a lyophilization process yielding a microbiologically stable preparation that retains the biological activity of the ingredients. Available as a powder, the material of the invention can be conveniently stored and transported for commercial applications. The process ensures that the biological activity of the heat sensitive growth hormones is retained, and that the RNA phosphorus/DNA-phosphorus ratio and the amino acid composition are optimized for maximum biological activity.
  • the process employs a lyophilization technique, which preserves the biological activity of the active ingredients.
  • the liquid endosperm obtained from fresh green coconuts at their peak level of maturity, is frozen at ⁇ 20° C. to ⁇ 70° C. using a mixture of solid carbon dioxide-acetone, followed by lyophilization in a customized lyophilizer at a reduced pressure of 0.1 to 0.8 mm Hg and a temperature of 35° C. to 40° C. to produce a lyophilized amorphous material.
  • the amorphous nature of the freeze dried material protects the protein components during pulverization and storage. During storage, the material transforms into the more stable crystalline state which is also less hygroscopic.
  • the amorphous material is pulverized under low temperature conditions to yield a powder.
  • shikimic and quinic acids content and their activity in the dried powder provide unexpected advantages over the fresh material.
  • the shikimic acid pathway is reported to produce salicylic acid, a known growth promoter in plants.
  • shikimic acid and quinic acid function as potent antioxidants.
  • Indole-3-acetic acid (plant auxin) the activity of which is retained in the dried product, has been shown to protect mammalian cells (sperm cells).
  • the product can be used in topical and cosmetic formulations to promote cell growth such as in skin care and hair care formulations as well as in dry blends for nutritional and sports beverages.
  • the invention is also useful as an inhibitor of tumor cell proliferation in mammalian cells.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Dairy Products (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Processing Of Solid Wastes (AREA)
  • Catalysts (AREA)
  • Water Treatment By Sorption (AREA)
  • Seeds, Soups, And Other Foods (AREA)

Abstract

A nutritional, cosmetic and pharmaceutical compositions containing active ingredients from the liquid endosperm of fresh green coconuts, and a method for obtaining the active ingredients.

Description

This application claims priority to provisional application No. 60/248,223 filed on Nov. 15, 2000.
FIELD OF THE INVENTION
The invention relates to nutritional, cosmetic and pharmaceutical compositions containing active ingredients from fresh green coconuts, and methods for obtaining the compositions.
BACKGROUND OF THE INVENTION
Coconut water is the liquid endosperm of Cocos nucifera L an is used as a supplement in media for the growth of plant tissue cultures. The coconut fruit is unique in that it accumulates large amounts of this liquid over periods of a year or more in its life cycle. The greatest amount of coconut water is found in young, green coconuts and provides nourishment for the growth of the solid endosperm (coconut meat) inside the hard shell of the fruit. When the fruit matures, both the solid endosperm and the remaining coconut water serve as nutrients for the developing embryo and seedling. Thus coconut water serves as a natural reservoir of nutrients to promote tissue growth1.
The nutritional composition of coconut water obtained from fruits at different stages of maturity has been determined. The medium is rich in proteins, amino acid sugars, vitamins, minerals and growth hormones (Table 1) essential to the promotion of tissue growth. In addition, shikimic acids and quinic acids have been detected in samples of coconut water from fruits at different stages of maturity, with the maximum amounts being found in young green coconuts. The probable role of these alicyclic acids in romatic biosynthesis, indicates their importance in the developing coconut. They may also play a significant role in the nutrition of plant and tissue cultures.
TABLE 1
VITAMIN, GROWTH FACTOR, SUGAR ALCOHOL AND
MINERAL CONTENT OF COCONUT WATER
Figure US07300682-20071127-C00001
Figure US07300682-20071127-C00002
COMPOUND Mg/L
Nicotinic acid 0.64
Pantothenic acid 0.52
Biotin 0.02
Riboflavin 0.01
Folic acid 0.003
Thiamine Trace
Pyridoxime Trace
Auxin 0.07
Gibberellin *
1,3-Diphenylurea 5.8
Sorbitol 15.0
M-inositol 0.01
Scyllo-inositol 0.05
Mg/100 g
Potassium 312.0
Chloride 183.0
Sodium 105.0
Phosphorous 37.0
Magnesium 30.0
Sulfur 24.0
Iron 0.10
Copper 0.04
* A significant growth response was obtained from dwarf peas with an extract of 188 ml of coconut water.
The RNA-phosphorus (RNA-P) content of coconut water was found to be consistently high at all levels of fruit maturity (Table 2). The ratio of RNA-P/DNA-P was unusually high. The role of RNA in amino acid transport and respiratory metabolism of living cells is well known. The RNA of coconut water would therefore effectively carry out these and other functions as part of the metabolic machinery essential to the developing endosperm tissue of the coconut and therefore support the growth of other living cells as well, in tissue culture media.
TABLE 2
RNA-PHOSPHORUS AND DNA-PHOSPHORUS OF THE
ALCOHOL-INSOLUBLE RESIDUE FROM COCONUT WATER
μG/mg alcohol-insoluble
residue Ratio
Age of coconuts RNA-P DNA-P RNA-P/DNA-P
Young green 20.05 0.06 342.5
Mature, green 32.82 2.45 13.9
Cytokinins are a class of plant growth substances (plant hormones) active in promoting cell division. They are also involved in cell growth and differentiation and in other physiological processes. A major cytokinin found in coconut milk was isolated using a standard procedure, the tobacco callus growth-promoting assay. The structure was determined to be a complex trans-zeatin riboside (G3A2-ZR). The authors of this study attributed at least 20% of the cytokinin activity in coconut milk to this compound2.
A study that explored the efficacy of single and combined growth regulator treatments of indole-3-acetic acid (IAA), gibberelic acid (GA3) and coconut milk on plant height, yield, chlorophyll and vitamin contents of plants such as Abelmoschus esculetus L and Solanum gilo L, found that 100 mg/L GA3 and 15% coconut water were significantly effective treatments3.
The nutritive properties of coconut water are well recognized in Oriental tradition. Immature coconuts are used as a glucose-electrolyte oral re-hydration solution for treatment of diarrhea4. Coconut water solids also provide a nutritive medium for beneficial microflora in the gastrointestinal tract. A recent report also mentions the successful use of coconut water as a short-term intravenous hydration fluid5. Coconut water has been used traditionally as a nutritional beverage. The FAO was recently granted a patent in the UK for the manufacture of bottled coconut water that retained all nutrients. This is the first patent given to a UN agency. Unlike existing methods their process did not use HTST pasteurization, wherein heat treatment would inactivate some of the biological activity of the coconut water.
Other researchers have obtained an extract from coconut water and milk called Cocogro, a natural product comprised of plant growth hormones and regulators, which enhances the growth of vegetables, legumes fruit trees, cereal crops, flowering plants, etc.
Green coconut milk is reported to be an effective culture medium for animal cells (Rev Bras Biol. 1970(Apr) 30:1:97-100) and Plasmodium (Trans. R. Soc. Trop. Med Hyg. 1989 83:5, 720). A major cytokinin, G3A2-ZR, was also identified in coconut milk (Kobayashi, H: et al. Experentia, 1995 51:11 1081-84).
Although coconut milk has been used traditionally on the skin as a nourishing agent, green coconut water provides unique nutrients for sustaining cell growth. For example, a protein fraction isolated from coconut water was absent in the milk (Birosel, DM et al. Rev. Farm Bioquim Univ Sao Paulo 1976 14:35-42).
Coconut milk is used in a facemask in U.S. Pat. No. 5,660,840 and in a plant growth regulating composition in U.S. Pat. No. 5654255.
Coconut water was found to be safe for topical use. In laboratory studies, the material is shown to have no irritating effects on the skin, and the LD50 value must be greater than 2000 mg/kg when administered through the skin. Accordingly, coconut water is nontoxic.
Coconut water is described as an isotonic sports drink. The comparative properties of coconut water and conventional sports drinks are listed in Table 37:
TABLE 3
SPORTS DRINKS VS. COCONUT WATER
Sports drinks Coconut water
Component (mg/100 ml) (mg/100 ml)
Potassium 11.7 294
Sodium 41 25
Chloride 39 118
Magnesium 7 10
Sugars 6 5
DETAILED DESCRIPTION OF THE INVENTION
An object of the invention relates to compositions containing as active ingredients, components obtained from coconut water. The compositions are specifically formulated for use in tissue culture media, more preferably, in supporting or culturing cells and mammalian tissues derived from ectoderm, mesoderm and endoderm.
The composition may be used in topical applications, for example, skin and hair care formulations. The composition may also be formulated into a nutritional supplement so as to be administered by ingestion or intravenously, thereby providing essential nutrients and repair material for the tissues.
The active ingredients of coconut water can be obtained by freeze-drying, and this simple method yields a unique and stable composition with optimum biological activity.
The inventive composition contains optimal amounts of growth hormones (cytokinins) and RNA-phosphorus (RNA-P), an optimal ratio of RNA-P/DNA-P, as well as desired concentrations of shikimic, quinic and indole-3-acetic acids. The inventive composition of the invention differs unexpectedly from that found in raw coconut water, and a list of its components is presented in Table 4.
TABLE 4
Composition of the invention
Substance Range
Total protein 0.9-1.2%
Carbohydrates 75-85%
Sodium 350-500 mg/100 g
Potassium 3000-4000 mg/100
Magnesium 200-300 mg/100 g
Cytokinins 0.01-0.03 mg/g
Indole-3-acetic acid 0.005-0.01 mg/g
Shikimic/quinic acids 25-30 Meq/mg
RNA-P content 25-30 μg/g alcohol-
insoluble residue
RNA-P/DNA-P ratio 300:1-400:1
The RNA-P/DNA-P ratio is 300:1 to 400:1. This is based on literature reports wherein the RNA-P of 20.05 mcg/g was associated with DNA-P 0.06 mcg/g of the alcohol-insoluble residue. RNA-P/DNA-P was therefore approximately 340:1.
Another object of the invention is a unique process for preserving the natural growth promoting properties of green coconut water. The nutritional properties of green coconut water are optimized by a lyophilization process yielding a microbiologically stable preparation that retains the biological activity of the ingredients. Available as a powder, the material of the invention can be conveniently stored and transported for commercial applications. The process ensures that the biological activity of the heat sensitive growth hormones is retained, and that the RNA phosphorus/DNA-phosphorus ratio and the amino acid composition are optimized for maximum biological activity.
The process employs a lyophilization technique, which preserves the biological activity of the active ingredients. The liquid endosperm, obtained from fresh green coconuts at their peak level of maturity, is frozen at −20° C. to −70° C. using a mixture of solid carbon dioxide-acetone, followed by lyophilization in a customized lyophilizer at a reduced pressure of 0.1 to 0.8 mm Hg and a temperature of 35° C. to 40° C. to produce a lyophilized amorphous material. The amorphous nature of the freeze dried material protects the protein components during pulverization and storage. During storage, the material transforms into the more stable crystalline state which is also less hygroscopic. The amorphous material is pulverized under low temperature conditions to yield a powder.
The shikimic and quinic acids content and their activity in the dried powder provide unexpected advantages over the fresh material. The shikimic acid pathway is reported to produce salicylic acid, a known growth promoter in plants. In other systems, shikimic acid and quinic acid function as potent antioxidants. Indole-3-acetic acid (plant auxin), the activity of which is retained in the dried product, has been shown to protect mammalian cells (sperm cells).
The product can be used in topical and cosmetic formulations to promote cell growth such as in skin care and hair care formulations as well as in dry blends for nutritional and sports beverages. The invention is also useful as an inhibitor of tumor cell proliferation in mammalian cells.
REFERENCES
    • 1. Tulecke, W. et al. (1961) The biochemical composition of coconut water (coconut milk)** as related to its use in plant tissue culture. Contributions from Boyce Thompson Institute, 21:115-128.
    • 2. Kobayashi, H. et al. (1995) Identification of a major cytokinin in coconut milk. Experentia 51(11):1081-1084.
    • 3. Kadiri, M. et al. (1 997) Responses of some Nigerian vegetables of plant growth. Rev. Biol Trop. 44-45:23-28.
    • 4. Adams, W. and Bratt, D E. (1992) Young coconut water for home rehydration in children with mild gastroenteritis. Trop. Geogr. Med. 44:149-53.
    • 5. Campbell-Falck, D. et al. (2000) The intravenous use of coconut water. Am J. Emerg. Med 18(1):108-11.
    • 6. Research Report #6719 and 6720. Indian Institute of Toxicology. May 2000. FAO: Agriculture21, New sports drink: coconut water. October 1998.
    • 7. Ma Y, Xu Q P, Sun J N, Bai L M, Guo Y J, Niu J Z Antagonistic effects of shikimic acid against focal cerebral ischemia injury in rats subjected to middle cerebral artery thrombosis. Chung Kuo Yao Li Hsueh Pao 1999 Aug.;20(8):701-4
    • 8. Aghil O, Bibby M C, Carrington S J, Double J, Douglas K T, Phillips R M, Shing T K Synthesis and cytotoxicity of shikimate analogues. Structure:activity studies based on 1-crotonyloxymethyl-3R,4R,5R-trihydroxycyclohex-2-enone. Anticancer Drug Des 1992 Feb.;7(1):67-82
    • 9. Jones R S, Ali M, Ioannides C, Styles J A, Ashby J, Sulej J, Parke D V The mutagenic and cell transforming properties of shikimic acid and some of its bacterial and mammalian metabolites. Toxicol Lett 1983 Oct.-Nov.;19(1-2):43-50
    • 10. Toniolli R, Bussiere J, Courot M, Magistrini M, Combarnous Y Effect of indole-3-acetic acid (plant auxin) on the preservation at 15 degrees C. of boar semen for artificial insemination. Reprod Nutr Dev 1996;36(5):503-11
    • 11. Nalini N, Sabitha K, Chitra S, Viswanathan P, Menon V P Histopathological and lipid changes in experimental colon cancer: effect of coconut kernel (Cocos nucifera Linn.) and (Capsicum annum Linn.) red chili powder. Indian J Exp Biol 1997 September;35(9):964-71.

Claims (13)

1. A lyophilized, nutritional composition from liquid endosperm of fresh green coconuts (Cocos nucifera L.) comprising proteins, carbohydrates, cytokinins, ribonucleic acid-phosphorus (RNA-P), deoxyribonucleic acid-phosporous (DNA-P), indole-3-acetic acid, shikimic acid and quinic acid.
2. The composition of claim 1, wherein the RNA-P and the DNA-P are at a ratio in a range of 300:1 to 400:1.
3. The composition of claim 1, wherein the shikimic acid is at a concentration range of 25-30 Meq/mg.
4. The composition of claim 1, wherein the quinic acid is at a concentration range of 25-30 Meq/mg.
5. The composition of claim 1, wherein the cytokinins are at a concentration range of 0.01-0.03 mg/g.
6. The composition of claim 1, wherein the indole-3-acetic acid is at a concentration range of 0.005-0.01 mg/g.
7. The composition of claim 1, wherein the composition is a powder.
8. A cosmetic formulation comprising a composition of claim 1.
9. A nutritional supplement for a beverage comprising a composition of claim 1.
10. A process for obtaining a biologically active powder from fresh green coconuts (Cocos nucifera L.) comprising the steps of:
a) providing liquid endosperm from coconuts;
b) freezing the liquid endosperm using a mixture of carbon dioxide and acetone to obtain a frozen liquid endosperm;
c) lyophilizing the frozen liquid endosperm of step b) to produce an amorphous material; and
d) pulverizing the amorphous material of step c) to obtain the biologically active powder.
11. The process of claim 10, wherein the liquid endosperm is frozen at a temperature range of from at −20° C. to −70° C.
12. The process of claim 10, wherein the lyophilizing of step c) occurs at a pressure of from 0.1 to 0.8 mm Hg and a temperature of from 35° C. to 40° C.
13. The process of claim 10, wherein the biologically active powder comprises proteins, carbohydrates, cytokinins, RNA-phosphorus (RNA-P), DNA-phosporous (DNA-P), indole-3-acetic acid, shikimic acid and quinic acid.
US10/416,017 2000-11-15 2001-11-15 Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance Expired - Lifetime US7300682B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/416,017 US7300682B2 (en) 2000-11-15 2001-11-15 Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24822300P 2000-11-15 2000-11-15
US10/416,017 US7300682B2 (en) 2000-11-15 2001-11-15 Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance
PCT/US2001/042948 WO2002040043A1 (en) 2000-11-15 2001-11-15 The method of preparation and use of coconut water in mamalian tissue nourishment, growth and healthy maintenance

Publications (2)

Publication Number Publication Date
US20040067264A1 US20040067264A1 (en) 2004-04-08
US7300682B2 true US7300682B2 (en) 2007-11-27

Family

ID=22938192

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/416,017 Expired - Lifetime US7300682B2 (en) 2000-11-15 2001-11-15 Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance

Country Status (7)

Country Link
US (1) US7300682B2 (en)
EP (1) EP1341547B1 (en)
AT (1) ATE341336T1 (en)
AU (1) AU2002233924A1 (en)
DE (1) DE60123655T2 (en)
DK (1) DK1341547T3 (en)
WO (1) WO2002040043A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178191A1 (en) * 2004-09-08 2007-08-02 Augustine Sebastian P Wine produced using tender coconut and product
US20180042875A1 (en) * 2015-03-03 2018-02-15 Nestec S.A. Compound use in promoting energy expenditure
JP2019506426A (en) * 2016-02-24 2019-03-07 サミ ラブズ リミテッド Adaptogen composition and use thereof
US11045444B2 (en) 2016-06-30 2021-06-29 Plume Cosmetics Inc. Composition and method for promoting eyelash and eyebrow growth exclusively containing naturally sourced ingredients

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501237B1 (en) * 2004-05-18 2006-11-15 Martins Antonio Dr Manufacturing coconut water with improved storage properties, subjects it to controlled thermal treatment followed by microfiltration and storage under inert atmosphere
US20080241285A1 (en) * 2007-04-01 2008-10-02 Muhammed Majeed Compositions and Methods to Treat Alopecia
IT1392474B1 (en) * 2008-12-10 2012-03-09 Sinerga S P A Ora Sinerga Group S R L COSMETIC AND DERMOPHARMACEUTICAL FORMULATIONS BASED ON SHIKIMIC ACID.
FR2957801A1 (en) * 2009-07-31 2011-09-30 Georges Camprasse Extracting active ingredients in mature Coco nucifera water, where the water is taken in a sterile manner by suction using a trocar connected to a peristaltic pump, introduced in one of germinal centers of the nut previously decontaminated
US8247003B2 (en) * 2009-08-07 2012-08-21 Muhammed Majeed Protective compositions for dermal papilla cells
BRPI1002346A2 (en) * 2010-07-19 2012-09-18 Fundacao Universidade Estadual Do Ceara process of obtaining dehydrated coconut water and resulting product
US20210084919A1 (en) * 2017-03-09 2021-03-25 Cocorilla Ltd System and method of preparing frozen coconuts
BR102019023798A2 (en) * 2019-11-12 2021-05-25 José Ferreira Nunes milk compost of coconut water and goat's milk and use of the compost
WO2022268659A1 (en) 2021-06-21 2022-12-29 Unilever Ip Holdings B.V. Use of coconut fruit juice for hygiene benefits and compositions thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736645A (en) 1954-12-03 1956-02-28 Frederick C Steward Compositions and method for regulating plant growth
CN1057161A (en) * 1991-06-14 1991-12-25 中山大学 Long-term preservation of coconut endosperm
JPH07322849A (en) * 1994-05-30 1995-12-12 Kao Corp Subsidiary food for treating or preventing hyperlipemia
US5654255A (en) 1995-06-05 1997-08-05 Basf Corporation Plant growth regulating compositions and methods
GB2318969A (en) 1996-11-04 1998-05-13 Food And Agriculture Organisat Coconut beverage
US5891440A (en) 1996-12-31 1999-04-06 Lansky; Ephraim Philip Phytoestrogen supplement prepared from pomegranate seeds and a herbal mixture or coconut milk

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736645A (en) 1954-12-03 1956-02-28 Frederick C Steward Compositions and method for regulating plant growth
CN1057161A (en) * 1991-06-14 1991-12-25 中山大学 Long-term preservation of coconut endosperm
JPH07322849A (en) * 1994-05-30 1995-12-12 Kao Corp Subsidiary food for treating or preventing hyperlipemia
US5654255A (en) 1995-06-05 1997-08-05 Basf Corporation Plant growth regulating compositions and methods
GB2318969A (en) 1996-11-04 1998-05-13 Food And Agriculture Organisat Coconut beverage
US5891440A (en) 1996-12-31 1999-04-06 Lansky; Ephraim Philip Phytoestrogen supplement prepared from pomegranate seeds and a herbal mixture or coconut milk

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
English language abstract of CN 1,057,161, Dec. 25, 1991.
PTO 2007-2523; Translation of CN 1057161 A, "Perennial Preservation Method for Coconut Endosperm", Translated by: Linguist System, Inc. *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178191A1 (en) * 2004-09-08 2007-08-02 Augustine Sebastian P Wine produced using tender coconut and product
US20180042875A1 (en) * 2015-03-03 2018-02-15 Nestec S.A. Compound use in promoting energy expenditure
JP2019506426A (en) * 2016-02-24 2019-03-07 サミ ラブズ リミテッド Adaptogen composition and use thereof
JP7220565B2 (en) 2016-02-24 2023-02-10 サミ－サビンサ グループ リミテッド Adaptogenic compositions and uses thereof
US11045444B2 (en) 2016-06-30 2021-06-29 Plume Cosmetics Inc. Composition and method for promoting eyelash and eyebrow growth exclusively containing naturally sourced ingredients

Also Published As

Publication number Publication date
WO2002040043A1 (en) 2002-05-23
ATE341336T1 (en) 2006-10-15
EP1341547A4 (en) 2004-08-25
AU2002233924A1 (en) 2002-05-27
EP1341547A1 (en) 2003-09-10
DE60123655T2 (en) 2007-10-04
EP1341547B1 (en) 2006-10-04
DE60123655D1 (en) 2006-11-16
DK1341547T3 (en) 2007-01-29
US20040067264A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
US7300682B2 (en) Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance
Adeyeye et al. Chemical composition of Cola acuminata and Garcinia kola seeds grown in Nigeria
CN103156073B (en) Nutritional supplement for postpartum dairy cows
EP1220680B1 (en) Echinacea supplement and method of manufacture
CN101774834B (en) Plant nutritional agent
CN115349528B (en) Composite preparation for preventing and treating early fallen leaves of fruit trees as well as preparation method and application thereof
Riad et al. Effect of Spirulina platensis microalga additive on performance of growing Friesian calves
JPWO2020195106A1 (en) Anti-obesity activator and obesity control method containing alitol as an active ingredient
US20030059479A1 (en) Cell activator
CN110432428A (en) Black coarse cereal powder of a kind of Hericium erinaceus five and preparation method thereof
KR20190017704A (en) Composition for stimulation of bone formation comprising Curcuma xanthorrhiza extract or xanthorrhizol as effective component
DE DK et al. KOKONUSSMILCH UND DEREN HERSTELLUNGSVERFAHREN EAU DE NOIX DE COCO ET SON PROCEDE DE PREPARATION
KR101418222B1 (en) Cultivation method of apple using chokeberry extract
US12011472B2 (en) Use of ramie extract in preparing a composition for improving the activity of mitochondria and improving the activity of telomerase
KR102457124B1 (en) Method for cultivating kale using geraniol and water stress and the use of it
KR102457123B1 (en) Method for cultivating kale with an increased sulforaphane content and the use of it
RU2764195C1 (en) Adaptogenic phytosynbiotic feed additive for calves
WO2022094663A1 (en) Composition
KR102560046B1 (en) Vitamin candy
Gouda et al. utilization of moringa oleifera as a new rabbits feed. 3-effect of dietary inclusion of moringa oleifera hay on reproductive performance of buck rabbits
JP7249036B2 (en) Antiallergic agent containing Korean ginseng extract extracted using silicate
RU2245062C2 (en) Curd-cereal product
Majeed et al. COCOCIN™: THE NOURISHMENT FACTOR™ FREEZE-DRIED COCONUT WATER SOLIDS
JP2007112750A (en) Nitric oxide production inhibitor
Zainhoum et al. Effect of Spraying Some Safe Substances on Yield and Fruits Quality of “Zaghloul” Date Palm

Legal Events

Date Code Title Description
AS Assignment

Owner name: SABINSA CORPORATION, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAJEED, MUHAMMED;BADMAEV, VLADIMIR;REEL/FRAME:014786/0438

Effective date: 20031024

AS Assignment

Owner name: SAMI LABS LTD., INDIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SABINSA CORPORATION;REEL/FRAME:015740/0981

Effective date: 20001218

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: 11.5 YR SURCHARGE- LATE PMT W/IN 6 MO, LARGE ENTITY (ORIGINAL EVENT CODE: M1556); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12